RL
Richard Law Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
45%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
71.4%
Neutral
14.3%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sell
Downgraded
| $10 |
40%
downside
| 1 | -13% |
0
%
| 15 Jan ‘26 3 days ago |
|
|
|
Buy
Upgraded
| $28 |
28%
upside
| 1 | +2.3% |
0
%
| 13 Jan ‘26 4 days ago |
|
|
|
Buy
Upgraded
| $67 |
20%
upside
| 1 | +5.1% |
0
%
| 12 Jan ‘26 5 days ago |
|
|
|
Buy
Maintained
| $38 |
40%
upside
| 2 | +133% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $135 |
29%
upside
| 1 | -3.5% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $29 |
12%
upside
| 1 | – |
–
| 30 Oct ‘25 2 months ago |
|